Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Magnetic Resonance Spectroscopy 26 pembrolizumab 17 Specimen Handling 17 Radiotherapy 17 Nivolumab 15 Cyclophosphamide 14 Temozolomide 11 Biopsy 11 Fluorodeoxyglucose F18 10 fludarabine 9 X-Rays 9 Etoposide 7 Bevacizumab 7 Standard of Care 6 Radiation 6 Paclitaxel 6 Dexamethasone 6 Cisplatin 6 Carboplatin 6 Surgical Procedures, Operative 5 Ipilimumab 5 Doxorubicin 5 Aspirin 5 venetoclax 4 olaparib 4 fluciclovine F-18 4 atezolizumab 4 abemaciclib 4 Vincristine 4 Rituximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × molgramostim × 1 year × Clear all

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡